We found that elevated CRP level at the time of MPMs diagnosis could predict VTE (p = .036) but not VTE mortality (p = .457) though literature identifies elevated CRP as a predictor of early mortality in cancer patients.39 The gene discussed is CRP; the disease is cancer.